Is there published data on tigecycline “related deaths” by age and gender?
No. The information provided here does not include any breakdown of tigecycline-related deaths by age group and gender, nor a source that reports those details.
What data is usually available instead of “tigecycline-related deaths” by age/sex?
In clinical safety reporting, drug labels and study results more commonly report:
- Overall death rates (all-cause mortality), not deaths deemed “related” to tigecycline.
- Deaths by general demographics (sometimes including age bands and sex) only when the trial or regulator publishes those subgroup summaries.
- Serious adverse event summaries where specific causality categories are not always available at the level of “related deaths by age and gender.”
Where to look if you need the actual age/sex breakdown
To produce the breakdown you’re asking for, you typically need at least one of the following:
- A regulatory safety dataset or post-marketing report that explicitly classifies deaths as drug-related and stratifies by age and sex.
- A clinical trial safety table that reports drug-related deaths by demographic subgroup.
If you tell me which setting you mean (for example, FDA label vs. EMA EPAR vs. a specific clinical trial or meta-analysis), I can help identify the most likely place those stratified “drug-related” death counts would appear.
Quick clarification that affects the answer
When you say “tigecycline related deaths,” do you mean:
- All-cause deaths that occurred during tigecycline treatment, or
- Deaths judged by clinicians/regulators as “related to” tigecycline (causality-assigned), or
- Deaths in specific adverse events (for example, sepsis, organ failure) where investigators concluded a relationship?
If you confirm which definition and the geography (FDA/EMA/other) or study/source you want, I can guide you to the exact table(s) needed for an age-by-gender breakdown.